Norovirus Infection in Older Adults: Epidemiology, Risk Factors, and Opportunities for Prevention and Control.

[1]  R. Montgomery,et al.  Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under‐recognized syndrome , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  L. Allen,et al.  Chronic Norovirus Infections in Cardiac Transplant Patients , 2017, Progress in transplantation.

[3]  M. Kirk,et al.  Norovirus Disease in Older Adults Living in Long-Term Care Facilities: Strategies for Management , 2017, Current Geriatrics Reports.

[4]  P. Okhuysen,et al.  Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center: a 10-year retrospective study , 2017, Infectious diseases.

[5]  Zhongjie Li,et al.  Incidence of Norovirus-Associated Diarrhea, Shanghai, China, 2012–2013 , 2017, Emerging infectious diseases.

[6]  S. Usuku,et al.  Norovirus genotype distribution in outbreaks of acute gastroenteritis among children and older people: an 8-year study , 2016, BMC Infectious Diseases.

[7]  E. Ryan,et al.  High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs , 2016, Front. Microbiol..

[8]  D. Graham,et al.  Replication of human noroviruses in stem cell–derived human enteroids , 2016, Science.

[9]  A. Shane,et al.  Molecular epidemiology of norovirus in children and the elderly in Atlanta, Georgia, United States , 2016, Journal of medical virology.

[10]  Heetae Lee,et al.  Antiviral effect of vitamin A on norovirus infection via modulation of the gut microbiome , 2016, Scientific Reports.

[11]  T. Yoshikawa,et al.  Norovirus Infections in Long‐Term Care Facilities , 2016, Journal of the American Geriatrics Society.

[12]  U. Parashar,et al.  Incidence of Norovirus and Other Viral Pathogens That Cause Acute Gastroenteritis (AGE) among Kaiser Permanente Member Populations in the United States, 2012–2013 , 2016, PloS one.

[13]  Sumit Sharma,et al.  Innate Resistance and Susceptibility to Norovirus Infection , 2016, PLoS pathogens.

[14]  U. Parashar,et al.  The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control , 2016, PLoS medicine.

[15]  M. Iturriza-Gómara,et al.  Age-Specific Incidence Rates for Norovirus in the Community and Presenting to Primary Healthcare Facilities in the United Kingdom. , 2016, The Journal of infectious diseases.

[16]  J. Brassard,et al.  The prevalence of enteric RNA viruses in stools from diarrheic and non-diarrheic people in southwestern Alberta, Canada , 2016, Archives of Virology.

[17]  B. Lopman,et al.  Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  K. Shioda,et al.  Outbreaks of Acute Gastroenteritis Transmitted by Person-to-Person Contact, Environmental Contamination, and Unknown Modes of Transmission--United States, 2009-2013. , 2015, Morbidity and mortality weekly report. Surveillance summaries.

[19]  Quanyi Wang,et al.  Human calicivirus occurrence among outpatients with diarrhea in Beijing, China, between April 2011 and March 2013. , 2015, Journal of medical virology.

[20]  P. van Damme,et al.  A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review , 2015, BMC Infectious Diseases.

[21]  A. Ersbøll,et al.  Norovirus Genotypes in Hospital Settings: Differences Between Nosocomial and Community-Acquired Infections. , 2015, The Journal of infectious diseases.

[22]  J. Mesquita,et al.  Surveillance of norovirus in Portugal and the emergence of the Sydney variant, 2011-2013. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  B. Lopman.  Global burden of norovirus and prospects for vaccine development , 2015 .

[24]  T. Leung,et al.  Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012–2014, Hong Kong , 2015, Scientific Reports.

[25]  P. Szilagyi,et al.  Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Vinjé,et al.  Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011-2012 , 2015, PloS one.

[27]  L. Ji,et al.  Prevalence and genetic diversity of noroviruses in adults with acute gastroenteritis in Huzhou, China, 2013–2014 , 2015, Archives of Virology.

[28]  A. Maeshima,et al.  Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography , 2015, International Journal of Hematology.

[29]  M. Koopmans,et al.  Burden of norovirus in healthcare facilities and strategies for outbreak control. , 2015, The Journal of hospital infection.

[30]  J. Vinjé,et al.  Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens , 2015, Gut microbes.

[31]  J. Vinjé,et al.  Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status , 2014, The Journal of infectious diseases.

[32]  John J. Treanor,et al.  178 – Noroviruses and Sapoviruses (Caliciviruses) , 2015 .

[33]  H. Uusi-Kerttula,et al.  High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children. , 2014, The Journal of infectious diseases.

[34]  Benjamin Lopman,et al.  Norovirus in healthcare settings , 2014, Current opinion in infectious diseases.

[35]  Marion Koopmans,et al.  Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. , 2014, The Lancet. Infectious diseases.

[36]  J. Vinjé,et al.  Infection control for norovirus. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  Jan Vinjé,et al.  Advances in Laboratory Methods for Detection and Typing of Norovirus , 2014, Journal of Clinical Microbiology.

[38]  Z. Duan,et al.  Clinical characteristics and genetic diversity of noroviruses in adults with acute gastroenteritis in Beijing, China in 2008–2009 , 2014, Journal of medical virology.

[39]  Aron J. Hall,et al.  Vital Signs: Foodborne Norovirus Outbreaks — United States, 2009–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[40]  J. Neyts,et al.  Norovirus: Targets and tools in antiviral drug discovery , 2014, Biochemical Pharmacology.

[41]  K. Green,et al.  Treatment of norovirus infections: moving antivirals from the bench to the bedside. , 2014, Antiviral research.

[42]  D. Graham,et al.  Determination of the 50% human infectious dose for Norwalk virus. , 2014, The Journal of infectious diseases.

[43]  I. Goodfellow,et al.  Norovirus gene expression and replication. , 2014, The Journal of general virology.

[44]  R. Black,et al.  Multiple Norovirus Infections in a Birth Cohort in a Peruvian Periurban Community , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  D. Smee,et al.  Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.

[46]  G. Bou,et al.  Role of norovirus in acute gastroenteritis in the Northwest of Spain during 2010–2011 , 2013, Journal of medical virology.

[47]  J. Vinjé,et al.  Genotypic and Epidemiologic Trends of Norovirus Outbreaks in the United States, 2009 to 2013 , 2013, Journal of Clinical Microbiology.

[48]  F. Rovida,et al.  Molecular detection of gastrointestinal viral infections in hospitalized patients , 2013, Diagnostic Microbiology and Infectious Disease.

[49]  Jan Vinjé,et al.  Norovirus Disease in the United States , 2013, Emerging infectious diseases.

[50]  Manoj Gambhir,et al.  Duration of Immunity to Norovirus Gastroenteritis , 2013, Emerging infectious diseases.

[51]  L. Gould,et al.  Acute Gastroenteritis Surveillance through the National Outbreak Reporting System, United States , 2013, Emerging infectious diseases.

[52]  Y. Chou,et al.  Epidemiological and molecular analysis of human norovirus infections in Taiwan during 2011 and 2012 , 2013, BMC Infectious Diseases.

[53]  S. Al-Dhahry,et al.  Characterising the aetiology of severe acute gastroenteritis among patients visiting a hospital in Qatar using real-time polymerase chain reaction , 2013, BMC Infectious Diseases.

[54]  Manish M Patel,et al.  Clinical characteristics of norovirus-associated deaths: a systematic literature review. , 2013, American journal of infection control.

[55]  M. Catton,et al.  Evaluation of the Bioline Standard Diagnostics SD immunochromatographic norovirus detection kit using fecal specimens from Australian gastroenteritis incidents. , 2013, Diagnostic microbiology and infectious disease.

[56]  Paul A. Gastañaduy,et al.  Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. , 2013, The Journal of infectious diseases.

[57]  D. Altmann,et al.  Epidemiology of norovirus gastroenteritis in Germany 2001–2009: eight seasons of routine surveillance , 2013, Epidemiology and Infection.

[58]  K. Bok,et al.  Norovirus gastroenteritis in immunocompromised patients. , 2012, The New England journal of medicine.

[59]  U. Parashar,et al.  The potential economic value of a human norovirus vaccine for the United States. , 2012, Vaccine.

[60]  A. Curns,et al.  Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. , 2012, JAMA.

[61]  Benjamin J Espinosa,et al.  Postinfectious gastrointestinal disorders following norovirus outbreaks. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  J. Müller-Nordhorn,et al.  Years of potential life lost for six major enteric pathogens, Germany, 2004–2008 , 2012, Epidemiology and Infection.

[63]  U. Parashar,et al.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  J. Garrett Morris,et al.  Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. , 2012, Journal of food protection.

[65]  J. Haagsma,et al.  The estimated disease burden of norovirus in The Netherlands , 2012, Epidemiology and Infection.

[66]  A. Curns,et al.  The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  D. Graham,et al.  Norovirus vaccine against experimental human Norwalk Virus illness. , 2011, The New England journal of medicine.

[68]  K. Templeton,et al.  Epidemiology and costs associated with norovirus outbreaks in NHS Lothian, Scotland 2007-2009. , 2011, The Journal of hospital infection.

[69]  J. Adachi,et al.  Norovirus gastroenteritis successfully treated with nitazoxanide. , 2011, The Journal of infection.

[70]  E. Naumova,et al.  Hospitalization of the elderly in the United States for nonspecific gastrointestinal diseases: a search for etiological clues. , 2011, American journal of public health.

[71]  T. Jiang,et al.  Genetic diversity of noroviruses in Chinese adults: potential recombination hotspots and GII-4/Den Haag-specific mutations at a putative epitope. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[72]  C. Umscheid,et al.  Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings , 2011, Infection Control & Hospital Epidemiology.

[73]  S. Sartori,et al.  Norovirus Gastroenteritis and Seizures: An Atypical Case with Neuroradiological Abnormalities , 2011, Neuropediatrics.

[74]  E. Thervet,et al.  Impact of Norovirus/Sapovirus-Related Diarrhea in Renal Transplant Recipients Hospitalized for Diarrhea , 2011, Transplantation.

[75]  E. Thiel,et al.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. , 2011, Blood.

[76]  Z. Duan,et al.  Clinical and Molecular epidemiologic analyses of norovirus‐associated sporadic gastroenteritis in adults from Beijing, China , 2011, Journal of medical virology.

[77]  S. Kaneko,et al.  Norovirus gastroenteritis accompanied by marked elevation of transaminases. , 2011, Hiroshima journal of medical sciences.

[78]  J. A. Boga,et al.  Noroviruses as cause of gastroenteritis in elderly patients , 2011, Aging clinical and experimental research.

[79]  J. Vinjé,et al.  Updated norovirus outbreak management and disease prevention guidelines. , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[80]  V. Hytönen,et al.  Prevalence of norovirus GII‐4 antibodies in Finnish children , 2011, Journal of medical virology.

[81]  A. Curns,et al.  Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  C. Heather,et al.  Diarrhoea in adults (acute). , 2008, BMJ clinical evidence.

[83]  F. Pessler,et al.  Can norovirus infection lead to a postinfectious arthritis? Report of 2 possible cases. , 2011, Klinische Padiatrie.

[84]  T. Eckmanns,et al.  High Level of Gastrointestinal Nosocomial Infections in the German Surveillance System, 2002–2008 , 2010, Infection Control & Hospital Epidemiology.

[85]  S. Kaneko,et al.  Norovirus gastroenteritis accompanied by ischemic colitis: a case report. , 2010, Hiroshima journal of medical sciences.

[86]  M. Kirk,et al.  Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  D. Graham,et al.  Serological correlate of protection against norovirus-induced gastroenteritis. , 2010, The Journal of infectious diseases.

[88]  V. Davidson,et al.  Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001–2004 , 2010, Epidemiology and Infection.

[89]  T. Fehr,et al.  Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  D. Jolley,et al.  An Outbreak of Necrotizing Enterocolitis Associated With Norovirus Genotype GII.3 , 2010, The Pediatric infectious disease journal.

[91]  J. Vinjé,et al.  Diagnostic Accuracy and Analytical Sensitivity of IDEIA Norovirus Assay for Routine Screening of Human Norovirus , 2010, Journal of Clinical Microbiology.

[92]  Laura C Rodrigues,et al.  Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. , 2010, American journal of epidemiology.

[93]  J. Vinjé,et al.  Epidemiological and genetic characteristics of norovirus outbreaks in long-term care facilities, 2003–2006 , 2010, Epidemiology and Infection.

[94]  M. Herbst-Kralovetz,et al.  Norwalk virus-like particles as vaccines , 2010, Expert review of vaccines.

[95]  G. De Sarro,et al.  Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes , 2010, European Journal of Clinical Pharmacology.

[96]  R. Pebody,et al.  Hospital admissions due to norovirus in adult and elderly patients in England. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[97]  R. Glass,et al.  Molecular Epidemiology of Genogroup II-Genotype 4 Noroviruses in the United States between 1994 and 2006 , 2009, Journal of Clinical Microbiology.

[98]  R. Benjamin,et al.  Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[99]  P. Cieslak,et al.  Recurring norovirus outbreaks in a long-term residential treatment facility - Oregon, 2007. , 2009, MMWR. Morbidity and mortality weekly report.

[100]  M. Estes,et al.  Norovirus gastroenteritis. , 2009, The New England journal of medicine.

[101]  Jan Vinjé,et al.  Noroviruses: a comprehensive review. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[102]  S. Huhulescu,et al.  Etiology of Acute Gastroenteritis in Three Sentinel General Practices, Austria 2007 , 2009, Infection.

[103]  W. Edmunds,et al.  Deaths from Norovirus among the Elderly, England and Wales , 2008, Emerging infectious diseases.

[104]  D. Graham,et al.  Norwalk Virus Shedding after Experimental Human Infection , 2008, Emerging infectious diseases.

[105]  G. Bruyn.  Diarrhea in adults (acute). , 2008 .

[106]  H. Schroten,et al.  Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus , 2008, Journal of medical virology.

[107]  P. Teunis,et al.  Norwalk virus: How infectious is it? , 2008, Journal of medical virology.

[108]  J. Greig,et al.  Enteric outbreaks in long-term care facilities and recommendations for prevention: a review , 2008, Epidemiology and Infection.

[109]  Kyeong-Ok Chang,et al.  Interferons and Ribavirin Effectively Inhibit Norwalk Virus Replication in Replicon-Bearing Cells , 2007, Journal of Virology.

[110]  S. Cosgrove,et al.  Outbreak management and implications of a nosocomial norovirus outbreak. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[111]  H. Vennema,et al.  European Multicenter Evaluation of Commercial Enzyme Immunoassays for Detecting Norovirus Antigen in Fecal Samples , 2007, Clinical and Vaccine Immunology.

[112]  T. Uzu,et al.  Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[113]  M. Iturriza-Gómara,et al.  Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996) , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[114]  M. Thabane,et al.  Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[115]  H. Rüden,et al.  Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature , 2007, Journal of Hospital Infection.

[116]  Norovirus activity--United States, 2006-2007. , 2007, MMWR. Morbidity and mortality weekly report.

[117]  J. Rossignol,et al.  Nitazoxanide in the treatment of viral gastroenteritis: a randomized double‐blind placebo‐controlled clinical trial , 2006, Alimentary pharmacology & therapeutics.

[118]  R. Johnston,et al.  Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. , 2006, Vaccine.

[119]  M. Estes,et al.  The epidemiologic and clinical importance of norovirus infection. , 2006, Gastroenterology clinics of North America.

[120]  R. Glass,et al.  Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[121]  H. Vennema,et al.  Risk groups for clinical complications of norovirus infections: an outbreak investigation. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[122]  B. Böttiger,et al.  Imported frozen raspberries cause a series of norovirus outbreaks in Denmark, 2005. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[123]  R. Heffernan,et al.  Three years of emergency department gastrointestinal syndromic surveillance in New York City: what have we found? , 2005, MMWR supplements.

[124]  K. Hedlund,et al.  Detection of noroviruses in raspberries associated with a gastroenteritis outbreak. , 2004, International journal of food microbiology.

[125]  H. Kelly,et al.  Long-term features of norovirus gastroenteritis in the elderly. , 2004, The Journal of hospital infection.

[126]  J. Sarangi,et al.  Clinical manifestation of norovirus gastroenteritis in health care settings. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[127]  J. Gray,et al.  Asymptomatic and Symptomatic Excretion of Noroviruses during a Hospital Outbreak of Gastroenteritis , 2004, Journal of Clinical Microbiology.

[128]  W. Lim,et al.  High rate and changing molecular epidemiology pattern of norovirus infections in sporadic cases and outbreaks of gastroenteritis in Hong Kong , 2004, Journal of medical virology.

[129]  C. Hanger,et al.  Norovirus outbreaks in a hospital setting: the role of infection control. , 2004, The New Zealand medical journal.

[130]  Todd Brown.  Norovirus activity—United States, 2002☆ , 2003 .

[131]  C. Tacket,et al.  Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. , 2003, Clinical immunology.

[132]  Xi Jiang,et al.  Human susceptibility and resistance to Norwalk virus infection , 2003, Nature Medicine.

[133]  Benjamin A Lopman,et al.  Two Epidemiologic Patterns of Norovirus Outbreaks: Surveillance in England and Wales, 1992–2000 , 2003, Emerging infectious diseases.

[134]  R. Baric,et al.  Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice , 2002, Journal of Virology.

[135]  R. Glass,et al.  Outbreak of acute gastroenteritis associated with Norwalk-like viruses among British military personnel--Afghanistan, May 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[136]  Y. V. van Duynhoven,et al.  Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. , 2001, American journal of epidemiology.

[137]  G. T. Strickland.  Hunter's Tropical Medicine and Emerging Infectious Diseases , 2019 .

[138]  J. Wells,et al.  Outbreaks of enterotoxigenic Escherichia coli infection in American adults: a clinical and epidemiologic profile , 1999, Epidemiology and Infection.

[139]  D. Graham,et al.  Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. , 1999, Gastroenterology.

[140]  C. Gaulin,et al.  Épidémie de gastro-entérite d'origine virale associée à la consommation de framboises importées , 1999 .

[141]  C. Gaulin,et al.  [Epidemic of gastroenteritis of viral origin associated with eating imported raspberries]. , 1999, Canadian journal of public health = Revue canadienne de sante publique.

[142]  R. Glass,et al.  A multistate outbreak of oyster-associated gastroenteritis: implications for interstate tracing of contaminated shellfish. , 1995, The Journal of infectious diseases.

[143]  M. Estes,et al.  Sequence and genomic organization of Norwalk virus. , 1993, Virology.

[144]  M. Osterholm,et al.  Outbreaks of food-borne and waterborne viral gastroenteritis , 1993, Clinical Microbiology Reviews.

[145]  D. Graham,et al.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein , 1992, Journal of virology.

[146]  H. Dupont,et al.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. , 1990, The Journal of infectious diseases.

[147]  F. A. Akbar,et al.  Diphenoxylate hydrochloride (Lomotil) in the treatment of acute diarrhoea. , 1987, The British journal of clinical practice.

[148]  J. Hanrahan,et al.  Widespread outbreaks of clam- and oyster-associated gastroenteritis. Role of Norwalk virus. , 1986, The New England journal of medicine.

[149]  H. Greenberg,et al.  Serological responses among teenagers after natural exposure to Norwalk virus. , 1984, The Journal of infectious diseases.

[150]  R. Feldman,et al.  The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. , 1982, American journal of public health.

[151]  R. Douglas,et al.  Bismuth subsalicylate therapy of viral gastroenteritis. , 1980, Gastroenterology.

[152]  A. Kapikian,et al.  Clinical immunity in acute gastroenteritis caused by Norwalk agent. , 1977, The New England journal of medicine.

[153]  R. Chanock,et al.  Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. , 1974, The Journal of infectious diseases.